LIPT1P1

Across TCGA pan-cancer cohorts, LIPT1P1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated LIPT1P1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LIPT1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LIPT1P1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and LGG show a favorable association.

BLCA, LUAD, and LUSC are the cancer types where LIPT1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	IV	0.089	0.480	<.001	72	view →
LUAD	DFS	Tertile	IV	0.109	0.714	.001	36	view →
LUSC	DFS	Tertile	III,IV	0.079	0.751	.024	30	view →
KIRC	DFS	Tertile	All	0.939	0.857	.005	24	view →
ACC	DFS	Tertile	II,III,IV	0.234	0.745	<.001	18	view →
STAD	DFS	Tertile	All	0.459	0.575	.025	9	view →
LGG	OS	Tertile	All	0.902	0.760	.006	8	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

LIPT1P1–BLCA (DFS)

Open the BLCA breakdown →